Latest News from: American College of Rheumatology (ACR)

Add to Favorites Subscribe Share
newswise-fb-share-

Showing results

110 of 546
ACR-Logo-2019 .jpg

Article ID: 714183

2019 ACR/ARP Annual Meeting Press Registration Opens

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) and the Association for Rheumatology Professionals (ARP) welcomes members of the press to write about research presented at the 2019 ACR/ARP Annual Meeting.

Released:
10-Jun-2019 2:05 PM EDT
ACR-Logo-2019 .jpg

Article ID: 713123

American College of Rheumatology Statement on CMS Medicare Advantage Final Rule

American College of Rheumatology (ACR)

In August 2018, the CMS announced that Medicare Advantage (MA) plans would be allowed to utilize step therapy for Part B drugs. The American College of Rheumatology (ACR) expressed strong concerns about this proposal. The rheumatology community received some good news in this week’s final rule from CMS, which makes changes to the original proposal and addresses several of our community’s recommendations.

Released:
17-May-2019 4:50 PM EDT
ACR-Logo-2019 .jpg

Article ID: 711882

The ACR and the Arthritis Foundation Present New Guidelines Offering Therapeutic Approaches and Treatment Options for Juvenile Idiopathic Arthritis

American College of Rheumatology (ACR)

Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA). One guideline aims to provide therapeutic approaches for non-systemic polyarthritis, sacroilitis and enthesitis; and the other focuses on the screening, monitoring and treatment of JIA with associated uveitis.

Released:
30-Apr-2019 3:00 PM EDT
ACR-Logo-2019 .jpg

Article ID: 711178

American College of Rheumatology Applauds Introduction of Bipartisan Step Therapy Legislation

American College of Rheumatology (ACR)

The American College of Rheumatology today praised Representative Raul Ruiz, MD (D-CA) and Representative Brad Wenstrup, MD (R-OH) for introducing the “Safe Step Act” (H.R. 2279). If enacted, H.R. 2279 would place reasonable parameters around the use of step therapy among employer-sponsored health plans.

Released:
11-Apr-2019 1:05 PM EDT
ACR-Logo-2019 .jpg

Article ID: 710946

ACR Leads Group Urging CMS to Implement Patient Step Therapy Safeguards and Clarify Existing Protections

American College of Rheumatology (ACR)

The American College of Rheumatology and 24 other patient and provider organizations are calling on CMS to immediately add step therapy safeguards to the agency's proposal allowing Medicare Advantage plans to utilize step therapy for Part B drugs.

Released:
8-Apr-2019 4:10 PM EDT
ACR-Logo-2019 .jpg

Article ID: 710530

American College of Rheumatology Targets Step Therapy and Drug Pricing in New Position Statements

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and accessible.

Released:
1-Apr-2019 9:05 AM EDT
ACR-Logo-2019 .jpg

Article ID: 708777

COMPLIMENTARY PRESS REGISTRATION AVAILABLE FOR 2019 STATE-OF-THE-ART CLINICAL SYMPOSIUM

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented at the State-of-the-Art Clinical Symposium (SOTA) in Chicago, IL, on April 5-7.

Released:
27-Feb-2019 12:15 PM EST
ACR-Logo-2019 .jpg

Article ID: 707050

American College of Rheumatology Responds to CMS Medicare Part D and Medicare Advantage Proposed Rule

American College of Rheumatology (ACR)

In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) expressed its continuing concern with a recent CMS policy allowing Medicare Advantage (MA) plans to utilize step therapy for Part B drugs. In the comment letter, rheumatology leaders urged the agency to establish safeguards to protect beneficiaries from potential harm.

Released:
24-Jan-2019 3:05 PM EST
ACR-Logo-2019 .jpg

Article ID: 705846

Rheumatology Community Urges CMS to Proceed with Caution When Considering IPI Drug Pricing Model

American College of Rheumatology (ACR)

– In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) urged the agency to proceed with caution when considering the International Pricing Index (IPI) drug pricing model, which was announced in an Advance Notice of Proposed Rulemaking in October.

Released:
27-Dec-2018 1:05 PM EST
ACR-Logo-2019 .jpg

Article ID: 704771

National Rheumatology and Psoriasis Organizations Release Joint Guideline for Treating Psoriatic Arthritis

American College of Rheumatology (ACR)

The American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF) have released a joint treatment guideline for psoriatic arthritis (PsA) that provides evidence-based pharmacologic and non-pharmacologic recommendations on caring for treatment-naïve patients with active PsA and patients who continue to have active PsA despite treatment.

Released:
3-Dec-2018 12:30 PM EST

Showing results

110 of 546

Chat now!